Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of SHANK2 protein | affects expression | 20106945
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SHANK2 mRNA | affects expression | 16483693
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of SHANK2 mRNA | decreases expression | 20106945
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of SHANK2 mRNA | decreases expression | 20106945
|
C071834 |
glycidamide |
glycidamide results in decreased expression of SHANK2 mRNA | decreases expression | 17822822
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of SHANK2 mRNA | affects cotreatment|increases expression | 17183730
|
C475919 |
hydroxytamoxifen |
hydroxytamoxifen results in increased expression of SHANK2 mRNA | increases expression | 16849584
|
D005996 |
Nitroglycerin |
Nitroglycerin results in increased expression of SHANK2 mRNA | increases expression | 12102619
|
C025299 |
polyphenols |
polyphenols results in decreased expression of SHANK2 mRNA | decreases expression | 16293270
|
D012643 |
Selenium |
Selenium results in decreased expression of SHANK2 mRNA | decreases expression | 19244175
|
C105686 |
SU 5402 |
SU 5402 affects the expression of SHANK2 mRNA | affects expression | 15298682
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of SHANK2 mRNA | increases expression | 20106945
|
D013755 |
Tetradecanoylphorbol Acetate |
[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of SHANK2 mRNA | affects cotreatment|affects expression | 16979875
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of SHANK2 mRNA | affects cotreatment|increases expression | 17183730
|
D014810 |
Vitamin E |
Vitamin E results in decreased expression of SHANK2 mRNA | decreases expression | 19244175
|
D015032 |
Zinc |
[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of SHANK2 mRNA | affects cotreatment|affects expression | 16979875
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.38 | 15322242 14514962 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
8.38 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.93 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.58 | 18287403 |
MESH:D000169 |
Acrodermatitis |
|
Zinc |
5.42 | 16889938 17190629 17202136 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
1.98 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.65 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.40 | 16835633 |
MESH:D000544 |
Alzheimer Disease |
|
Zinc |
2.76 | 16410023 17119284 16325427 16580781 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.26 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.95 | 11748828 |
MESH:D000755 |
Anemia, Sickle Cell |
|
Zinc |
4.91 | 16916123 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.57 | 17497229 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.09 | 19183758 |
MESH:D001249 |
Asthma |
|
Zinc |
2.95 | 17085522 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 20473310 20531469 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.00 | 17507914 19460635 18985861 17157402 18558336 20603192 17688650 19232924 18316065 18940202 18177632 16609825 18396377 18775368 15238991 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.08 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.05 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.82 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.03 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.03 | 8888407 |
MESH:D001930 |
Brain Injuries |
|
Zinc |
4.70 | 17109824 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.90 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.90 | 20435547 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
3.94 | 16050911 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.80 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
1.96 | 12619106 21507988 12907637 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
7.68 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
7.68 | 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Zinc |
7.68 | 16543248 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.37 | 16120746 18670907 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
Zinc |
3.66 | 16936243 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.53 | 12371664 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.71 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.16 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
2.92 | 19486331 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.10 | 12621046 16354765 15340226 8697196 15668235 |
MESH:D003092 |
Colitis |
|
Selenium |
3.79 | 17936198 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
2.67 | 16293270 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.06 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
5.43 | 10048152 15322242 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
5.43 | 16575769 8888407 17688650 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
5.43 | 19769572 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Zinc |
5.43 | 19302082 |
MESH:D003920 |
Diabetes Mellitus |
|
Zinc |
4.21 | 16479319 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.67 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
9.03 | 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
9.03 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
9.03 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
9.03 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.76 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.06 | 1851702 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.73 | 9068938 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.97 | 12711302 11000095 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
6.97 | 16716910 15177302 11698051 8273558 8113982 7812673 9599246 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.93 | 18230668 15322242 16714409 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.02 | 9294722 10568697 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.17 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.95 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.94 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.59 | 6254150 7562514 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.31 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.08 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.64 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Zinc |
4.64 | 16543248 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.01 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
7.77 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
7.77 | 14986274 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.47 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.92 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.14 | 18558336 8888407 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.53 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.53 | 20067830 |
MESH:D005756 |
Gastritis |
|
Zinc |
4.83 | 17241300 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.24 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.62 | 10696789 |
MESH:D006130 |
Growth Disorders |
|
Zinc |
3.96 | 17217573 |
MESH:D006261 |
Headache |
|
Nitroglycerin |
5.22 | 11554966 11284996 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
11.11 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
11.11 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
11.11 | 16080930 |
MESH:D006333 |
Heart Failure |
|
Selenium |
7.35 | 17162251 |
MESH:D006333 |
Heart Failure |
|
Zinc |
7.35 | 17162251 |
MESH:D006335 |
Heart Injuries |
|
Zinc |
5.80 | 17074742 |
MESH:D016481 |
Helicobacter Infections |
|
Zinc |
4.54 | 17241300 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.44 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.34 | 11000095 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc |
4.70 | 17276780 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.91 | 16120746 15340226 12621046 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.70 | 16490937 16863852 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
4.00 | 14716179 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.89 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.08 | 18606429 8697196 16959395 16354765 15340226 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.95 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.95 | 18850075 18670907 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.64 | 16612254 |
MESH:D007249 |
Inflammation |
|
polyphenols |
8.47 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.47 | 12200463 12878042 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
8.47 | 11698051 7812673 8273558 15177302 7562506 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
11.06 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
11.06 | 16624496 |
MESH:D007511 |
Ischemia |
|
Zinc |
4.64 | 16584753 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.34 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.47 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
10.17 | 8314463 18776723 10903974 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
10.17 | 12488133 |
MESH:D007674 |
Kidney Diseases |
|
Zinc |
10.17 | 16960431 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
10.10 | 16518626 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Zinc |
10.10 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.74 | 12371664 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.15 | 16294345 17596541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.34 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
2.34 | 16169303 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
2.78 | 16698588 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
7.39 | 15890375 18177683 9163691 2125692 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
7.39 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.39 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
5.81 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.81 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
3.18 | 16863852 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.29 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
6.60 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
6.60 | 20464547 20135361 18569708 6695378 20064080 20869020 18520028 18816296 17053015 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.60 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
6.60 | 11807781 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
6.60 | 11062179 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
10.17 | 15318939 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
10.17 | 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Zinc |
10.17 | 12773700 |
MESH:D008607 |
Mental Retardation |
marker/mechanism |
|
| 20473310 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.79 | 15107826 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.82 | 16801185 |
MESH:D008708 |
Methemoglobinemia |
|
Nitroglycerin |
4.74 | 3537620 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.19 | 18803445 18765137 |
MESH:D020326 |
Migraine without Aura |
|
Nitroglycerin |
5.13 | 14659530 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.19 | 16381670 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.03 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.15 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Nitroglycerin |
3.78 | 14729435 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.02 | 12213967 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.17 | 11141357 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.47 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.29 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.22 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.13 | 16359493 8888407 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
3.13 | 15976015 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
4.31 | 12065085 18404319 18922899 8330346 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.28 | 12520081 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.92 | 15087411 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.57 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.22 | 12371664 |
MESH:D011225 |
Pre-Eclampsia |
|
Zinc |
4.18 | 17114810 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.53 | 11399792 11896295 11222880 11118676 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
9.53 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.63 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
2.63 | 15084515 |
MESH:D011471 |
Prostatic Neoplasms |
|
Zinc |
2.63 | 12429649 16700911 16517595 16606632 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.57 | 11422049 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.23 | 16882103 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.85 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Zinc |
4.13 | 16584753 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.18 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.07 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.74 | 11738929 17978042 14763951 16876388 1511512 11044598 15475178 3137016 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.44 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
9.48 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.48 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
9.48 | 8985016 8330346 11807781 12065085 18404319 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.78 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.57 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 2093021 20155912 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.52 | 16517955 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
5.28 | 17997062 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.93 | 12697716 |
MESH:D014062 |
Tongue Neoplasms |
|
Zinc |
4.40 | 16543248 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.26 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.54 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.18 | 17053015 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.66 | 8888407 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.01 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.62 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.28 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.47 | 17120751 |